Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 3, 2023. (Total: 223614Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 12 (of 12 Records)

Query Trace: Neoplasms and CALR[original query]
PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational status.
Thrombosis research 2016 Apr 140 Suppl 1 S183.
Vignoli A, Tessarolo S, Marchetti M, Gamba S, Piras F, Finazzi G, van der Meijden P E J, Swieringa F, Ten Cate H, Heemskerk J W M, Rambaldi A, Falanga
Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms.
Medical oncology (Northwood, London, England) 2017 May 34 (5): 83.
Chang Yu-Cheng, Lin Huan-Chau, Chiang Yi-Hao, Chen Caleb Gon-Shen, Huang Ling, Wang Wei-Ting, Cheng Chun-Chia, Lin Johnson, Chang Yi-Fang, Chang Ming-Chih, Hsieh Ruey-Kuen, Chen Shu-Jen, Lim Ken-Hong, Kuo Yuan-Y
[Exploratory study of circulating tumor DNA detection in early breast cancer: an analysis of 75 next-generation sequencing results].
Zhonghua wai ke za zhi [Chinese journal of surgery] 2017 Nov 55 (11): 847-852.
Zhou B, Xin L, Xu L, Liu Y H, Zhang M M, Jing R L, Liang X Y, Cao S
Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India.
Indian journal of pathology & microbiology 0 61 (2): 209-213.
Rabade Nikhil, Subramanian P G, Kodgule Rohan, Raval Goutham, Joshi Swapnali, Chaudhary Shruti, Mascarenhas Russel, Tembhare Prashant, Gujral Sumeet, Patkar Nikh
Classification and Personalized Prognosis in Myeloproliferative Neoplasms.
The New England journal of medicine 2018 10 379 (15): 1416-1430.
Grinfeld Jacob, Nangalia Jyoti, Baxter E Joanna, Wedge David C, Angelopoulos Nicos, Cantrill Robert, Godfrey Anna L, Papaemmanuil Elli, Gundem Gunes, MacLean Cathy, Cook Julia, O'Neil Laura, O'Meara Sarah, Teague Jon W, Butler Adam P, Massie Charlie E, Williams Nicholas, Nice Francesca L, Andersen Christen L, Hasselbalch Hans C, Guglielmelli Paola, McMullin Mary F, Vannucchi Alessandro M, Harrison Claire N, Gerstung Moritz, Green Anthony R, Campbell Peter
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer.
Journal for immunotherapy of cancer 2020 Nov 8 (2): .
Arai Hiroyuki, Xiao Yi, Loupakis Fotios, Kawanishi Natsuko, Wang Jingyuan, Battaglin Francesca, Soni Shivani, Zhang Wu, Mancao Christoph, Salhia Bodour, Mumenthaler Shannon M, Weisenberger Daniel J, Liang Gangning, Cremolini Chiara, Falcone Alfredo, Millstein Joshua, Lenz Heinz-Jos
Alterations of Signaling Pathways in Essential Thrombocythemia with Calreticulin Mutation.
Cancer management and research 2021 8 13 6231-6238.
Hui Wuhan, Zhang Wei, Liu Congyan, Wan Suigui, Sun Wanling, Su
Novel prognostic genes and subclasses of acute myeloid leukemia revealed by survival analysis of gene expression data.
BMC medical genomics 2021 Feb 14 (1): 39.
Lai Yanli, OuYang Guifang, Sheng Lixia, Zhang Yanli, Lai Binbin, Zhou Mi
VEGFA rs3025020 Polymorphism Contributes to CALR -Mutation Susceptibility and Is Associated with Low Risk of Deep Vein Thrombosis in Primary Myelofibrosis.
TH open : companion journal to thrombosis and haemostasis 2021 11 5 (4): e513-e520.
Villani Laura, Rosti Vittorio, Massa Margherita, Campanelli Rita, Catarsi Paolo, Carolei Adriana, Abbà Carlotta, de Silvstri Annalisa, Gale Robert Peter, Barosi Giovan
Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels.
Annals of hematology 2022 Oct .
Lewandowski Krzysztof, Kandu?a Zuzanna, Gniot Micha?, Paczkowska Edyta, Nawrocka Paulina Maria, Wojtaszewska Marzena, Janowski Micha?, Mariak Magdalena, Handschuh Luiza, Kozlowski Pio
The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience.
Cellular and molecular biology (Noisy-le-Grand, France) 2023 2 68 (8): 202-209.
Basim Najm Maysam, Jalal Sana Dlawar, Getta Hisham Ar
Characterization of myeloproliferative neoplasms in the paediatric and young adult population.
British journal of haematology 2023 1 .
Harris Zoey, Kaizer Hannah, Wei Aria, Karantanos Theodoros, Williams Donna M, Chaturvedi Shruti, Jain Tania, Resar Linda, Moliterno Alison R, Braunstein Evan
TOP